Price T Rowe Associates Inc Seagen Inc. Transaction History

Price T Rowe Associates Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $2.22 Million - $2.5 Million	-11,566 Reduced 1.85%	612,737 $130 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $179 Million - $197 Million	-956,513 Reduced 60.51%	624,303 $120 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $87.5 Million - $139 Million	685,883 Added 76.64%	1,580,816 $320 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $10.5 Million - $12.5 Million	89,624 Added 11.13%	894,933 $115 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $231 Million - $308 Million	-1,709,580 Reduced 67.98%	805,309 $110 Million

Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $254 Million - $419 Million	-2,336,066 Reduced 48.16%	2,514,889 $445 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $213 Million - $282 Million	-1,784,291 Reduced 26.89%	4,850,955 $699 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $50.6 Million - $67.7 Million	-354,618 Reduced 5.07%	6,635,246 $1.03 Billion
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $28.5 Million - $33.9 Million	199,759 Added 2.94%	6,989,864 $1.19 Billion
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $43.8 Million - $52.2 Million	-324,065 Reduced 4.56%	6,790,105 $1.07 Billion
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $56.7 Million - $78.6 Million	-412,070 Reduced 5.48%	7,114,170 $988 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $1.24 Billion - $1.6 Billion	7,526,240 New	7,526,240 $1.32 Billion

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.